These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21048105)

  • 21. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
    Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
    J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment of rapamycin before allogenic corneal transplant promotes graft survival through increasing CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Wang X; Wang W; Xu J; Hong J; Le Q
    Exp Clin Transplant; 2013 Feb; 11(1):56-62. PubMed ID: 22769982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical stoichiometric ratio of CD4(+)  CD25(+)  FoxP3(+) regulatory T cells and CD4(+)  CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia.
    Bhattacharya K; Chandra S; Mandal C
    Immunology; 2014 May; 142(1):124-39. PubMed ID: 24354800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice.
    Zhao L; Sun L; Wang H; Ma H; Liu G; Zhao Y
    J Leukoc Biol; 2007 Jun; 81(6):1386-94. PubMed ID: 17369496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.
    Han Y; Guo Q; Zhang M; Chen Z; Cao X
    J Immunol; 2009 Jan; 182(1):111-20. PubMed ID: 19109141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
    Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of regulatory T cells by physiological level estrogen.
    Tai P; Wang J; Jin H; Song X; Yan J; Kang Y; Zhao L; An X; Du X; Chen X; Wang S; Xia G; Wang B
    J Cell Physiol; 2008 Feb; 214(2):456-64. PubMed ID: 17654501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice.
    Liu H; Bakthavatsalam R; Meng Z; Li Z; Li W; Perkins JD; Reyes J
    Transplant Proc; 2013 Jun; 45(5):1853-5. PubMed ID: 23769057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors.
    El Andaloussi A; Han Y; Lesniak MS
    J Neurosurg; 2006 Sep; 105(3):430-7. PubMed ID: 16961139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
    Schabowsky RH; Madireddi S; Sharma R; Yolcu ES; Shirwan H
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1002-8. PubMed ID: 18058571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibiting effect of Astragalus polysaccharides on the functions of CD4+CD25 highTreg cells in the tumor microenvironment of human hepatocellular carcinoma.
    Li Q; Bao JM; Li XL; Zhang T; Shen XH
    Chin Med J (Engl); 2012 Mar; 125(5):786-93. PubMed ID: 22490576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of excreted/secreted antigens of Toxoplasma gondii on CD4+ CD25+ Foxp3+ T cells and NK cells of melanoma-bearing mice].
    Jiao YM; Zhang L; Ge YY; Liang YJ; Yong W
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):301-6. PubMed ID: 22164498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
    Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
    Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
    Cong L; Wang SF; Zhao ZL; Yang RY
    Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.
    Berntsen A; Brimnes MK; thor Straten P; Svane IM
    J Immunother; 2010 May; 33(4):425-34. PubMed ID: 20386464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.